18th Biosimilars conference

EVENT | 18th Biosimilar Medicines Conference

October 6, 2022

Asphalion Managing Director, Núria Romero, and Lidia Cánovas, General Manager, Regulatory Affairs, are attending the 18th Biosimilar Medicines Conference by MFE that is taking place in Brussels. At the Conference, speakers and panellists are exploring how to turn the Pharmaceutical Strategy with the aim to ensure better access and affordability into concrete biosimilar medicine policy measures.

Yannis Natsis Director of the European Social Insurance Platform (ESIP), has stated that solidarity and social protection have been key for having made Europe Different and that developing biosimilars is a question of solidarity and sustainability.

Also, Andrzej Rys Director for Health Systems and Products in the Directorate General for Health and Food Safety at the European Commission said that, in order to be competent with the 120 biologic molecules and to get these to become biosimilars, regulatory and legal changes are needed.

For further information you can check the conference website: https://www.medicinesforeurope.com/events/bios22/

If you require any other information, you can contact us at: info@asphalion.com

Search News & Events

  • Filter by category

Share

Related news and events

TMEX

TMex | TRANSLATIONAL MEDICINE COURSE

At TMex, several innovation sessions will take place, covering the business canvas model, critical success factor in the translational pathway and how to communicate your research to society.

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting